Table 1 Differences between the EuroSCORE and Lahr patient population
From: Creatinine clearance versus serum creatinine as a risk factor in cardiac surgery
A: Preoperative attributes | |||||
|---|---|---|---|---|---|
EuroSCORE | Lahr | ||||
diabetes mellitus | |||||
on insulin | 4.0% | 10.0% | |||
on oral therapy | 8.5% | 17.0% | |||
body mass index > 33 | 5.0% | 11.0% | |||
mean age (years) | 62.4 | 65.0 | |||
age > 75 years | 10.0% | 17.0% | |||
B: Risk distribution and mortality | |||||
EuroSCORE | Lahr | ||||
Risk | EuroSCORE value | Prevalence | Mortality | Prevalence | Mortality |
low | 0–2 | 30.6% | 0.8% | 27.0% | 0.34% |
medium | 3–5 | 40.4% | 3.1% | 39.7% | 1.4% |
high | ≥ 6 | 29.0% | 11.0% | 31.3% | 4.1% |